Bio-Techne Corporation (BVMF:T1CH34)

Bio-Techne Statistics

Total Valuation

Bio-Techne has a market cap or net worth of BRL 52.72 billion. The enterprise value is 53.61 billion.

Market Cap	52.72B
Enterprise Value	53.61B

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Nov 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.20%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	1.12%
Owned by Institutions (%)	108.51%
Float	154.58M

Valuation Ratios

The trailing PE ratio is 118.08 and the forward PE ratio is 31.12.

PE Ratio	118.08
Forward PE	31.12
PS Ratio	7.87
PB Ratio	4.76
P/TBV Ratio	13.76
P/FCF Ratio	42.92
P/OCF Ratio	38.39
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.10, with an EV/FCF ratio of 43.64.

EV / Earnings	120.07
EV / Sales	8.48
EV / EBITDA	29.10
EV / EBIT	37.94
EV / FCF	43.64

Financial Position

The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.17.

Current Ratio	4.54
Quick Ratio	2.59
Debt / Equity	0.17
Debt / EBITDA	0.99
Debt / FCF	1.57
Interest Coverage	29.15

Financial Efficiency

Return on equity (ROE) is 3.97% and return on invested capital (ROIC) is 8.75%.

Return on Equity (ROE)	3.97%
Return on Assets (ROA)	6.52%
Return on Invested Capital (ROIC)	8.75%
Return on Capital Employed (ROCE)	11.37%
Weighted Average Cost of Capital (WACC)	11.96%
Revenue Per Employee	2.16M
Profits Per Employee	144,025
Employee Count	3,100
Asset Turnover	0.47
Inventory Turnover	2.06

Taxes

In the past 12 months, Bio-Techne has paid 182.24 million in taxes.

Income Tax	182.24M
Effective Tax Rate	28.98%

Stock Price Statistics

The stock price has decreased by -14.36% in the last 52 weeks. The beta is 1.47, so Bio-Techne's price volatility has been higher than the market average.

Beta (5Y)	1.47
52-Week Price Change	-14.36%
50-Day Moving Average	10.42
200-Day Moving Average	11.96
Relative Strength Index (RSI)	49.24
Average Volume (20 Days)	50

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.04

Income Statement

In the last 12 months, Bio-Techne had revenue of BRL 6.70 billion and earned 446.48 million in profits. Earnings per share was 2.86.

Revenue	6.70B
Gross Profit	4.46B
Operating Income	1.49B
Pretax Income	628.96M
Net Income	446.48M
EBITDA	1.82B
EBIT	1.49B
Earnings Per Share (EPS)	2.86

Balance Sheet

The company has 988.93 million in cash and 1.93 billion in debt, with a net cash position of -943.80 million.

Cash & Cash Equivalents	988.93M
Total Debt	1.93B
Net Cash	-943.80M
Net Cash Per Share	n/a
Equity (Book Value)	11.08B
Book Value Per Share	71.06
Working Capital	2.74B

Cash Flow

In the last 12 months, operating cash flow was 1.37 billion and capital expenditures -144.84 million, giving a free cash flow of 1.23 billion.

Operating Cash Flow	1.37B
Capital Expenditures	-144.84M
Free Cash Flow	1.23B
FCF Per Share	n/a

Margins

Gross margin is 66.60%, with operating and profit margins of 22.28% and 6.67%.

Gross Margin	66.60%
Operating Margin	22.28%
Pretax Margin	9.39%
Profit Margin	6.67%
EBITDA Margin	27.19%
EBIT Margin	22.28%
FCF Margin	18.35%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 0.34%.

Dividend Per Share	0.04
Dividend Yield	0.34%
Dividend Growth (YoY)	3.55%
Years of Dividend Growth	2
Payout Ratio	61.50%
Buyback Yield	2.20%
Shareholder Yield	2.53%
Earnings Yield	0.85%
FCF Yield	2.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 30, 2022. It was a forward split with a ratio of 4.

Last Split Date	Nov 30, 2022
Split Type	Forward
Split Ratio	4

Scores

Bio-Techne has an Altman Z-Score of 12.36 and a Piotroski F-Score of 8.

Altman Z-Score	12.36
Piotroski F-Score	8